SOCAL: Overview of the RECONNECT Clinical Trial, CBD in FXS, and Q&A with Dr. Kristen Bzdek
Dr. Kristen Bzdek is a Senior Medical Director of Clinical Development at Harmony Biosciences where she is the Medical Lead of the ZYN002 program in Fragile X syndrome. She will be providing an overview of the RECONNECT trial and answering questions from attendees.
Join FRAXSOCAL for an insightful Zoom event on Tuesday, November 12 from 7 - 7:30pm PT / 10 - 10:30pm ET with Dr. Kristen Bzdek.
Dr. Bzdek will give an overview of the RECONNECT trial and answer questions. Don’t miss this opportunity to learn more!
There is not cost to attend this event.
Date
- November 19, 2024
Time
PT- 7:00 pm - 7:30 pm
Location
Organizer
-
FRAXSOCAL
-
Email
fragilexassociation@gmail.com -
Website
https://fraxsocal.org/